Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation
Objectives: We compared the effectiveness of bisphosphonates combined with activated vitamin D administered for therapy of aromatase inhibitor-induced osteoporosis after a breast cancer operation and primary postmenopausal osteoporosis through propensity score matching. Methods: Forty-eight postmeno...
Main Authors: | Mizue Tanaka, Soichiro Itoh, Yasuhiro Takeuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Osteoporosis and Sarcopenia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240552551830058X |
Similar Items
-
Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor
by: Somsri Wiwanitkit, et al.
Published: (2013-06-01) -
Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
by: Bauer M, et al.
Published: (2012-06-01) -
The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
by: Mizue Tanaka, et al.
Published: (2014-01-01) -
Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009) -
Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
by: Michael Dieckmeyer, et al.
Published: (2019-11-01)